
Gerald Lee, MD; Shyam Joshi, MD; Sarah Spriet, MD; Disclosures
Recorded March 18, 2026
AllergyWatch January/February 2026 issue
Interested in claiming CME for this episode? Click here
Today we are joined by Dr. Sarah Spriet, a Staff Allergist and Clinical Immunologist at Alexander T. Augusta Military Medical Center in Northern Virginia and an assistant editor of Allergy Watch. We will be reviewing the January/February 2026 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
For those currently listening to the audio version, we are now releasing video versions of AllergyTalk as well! Please visit the ACAAI YouTube channel at https://www.youtube.com/allergists
For information about CME credit, head over to http://education.acaai.org/allergytalk
To read archived issues of AllergyWatch, head over to http://college.acaai.org/publications/allergywatch
Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
- A proof-of-mechanism trial in asthma with lunsekimig, a bispecific NANOBODYmolecule.
- Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: Systematic review and network meta-analysis
- Food allergy clinical course in children and adolescents treated with dupilumab for atopic dermatitis.
Please rate our podcast on Apple Podcasts and YouTube!
Please give us feedback, corrections, and suggestions!
Email feedback to: [email protected]
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Speaker Disclosures back to top
Gerald Lee, MD
No relevant financial relationships with ineligible companies to disclose
Shyam Joshi, MD
No relevant financial relationships with ineligible companies to disclose
Sarah Spriet, DO
No relevant financial relationships with ineligible companies to disclose

Facebook
X
LinkedIn
Forward